Pfizer Inc (NYSE:PFE) Insider John Young unloaded 9,000 shares of Pfizer stock on the open market in a transaction that occurred on Monday, March 17th. Pfizer Inc. (NYSE:PFE) shares after opening at $31.41 moved to $32.06 on last trade day and at the end of the day closed at $31.93. Company price to sales ratio in past twelve months was calculated as 4.22 and price to cash ratio as 6.71. Pfizer Inc. (NYSE:PFE) showed a negative weekly performance of -1.51%.
On March 14, 2014, Merck & Co., Inc. (NYSE:MRK) announced that NOXAFIL® (posaconazole) injection (18 mg/ mL), a new formulation of NOXAFIL for intravenous (IV) use, was approved by the U.S. Food and Drug Administration (FDA). The Company stated that as a result of the approval, it now provides an IV formulation and two oral formulations of NOXAFIL for prophylaxis against invasive Aspergillus and Candida infections in high-risk patients.Merck & Co., Inc. (NYSE:MRK) shares advanced 0.18% in last trading session and ended the day on $56.36. Merck & Co., Inc. (NYSE:MRK) return on equity ratio is recorded as 12.10% and its return on assets is 5.60%. Merck & Co., Inc. (NYSE:MRK) yearly performance is 33.78%.
TheStreet Ratings team rates JOHNSON & JOHNSON (NYSE:JNJ) as a “buy” with a ratings score of A. Johnson & Johnson (NYSE:JNJ) shares moved up 0.01% in last trading session and was closed at $93.94, while trading in range of $93.48 – $94.24. Johnson & Johnson (NYSE:JNJ) year to date (YTD) performance is 3.30%.
Bristol-Myers Squibb Company (NYSE:BMY) daclatasvir grabbed headlines last April when a phase-two trial combining it with Sovaldi scored a 100% cure rate. Bristol-Myers Squibb Company (NYSE:BMY) weekly performance is -1.97%. On last trading day company shares ended up $54.73. Bristol-Myers Squibb Company (NYSE:BMY) distance from 50-day simple moving average (SMA50) is 2.59%. Analysts mean target price for the company is $55.06.
Leave a Reply